TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat-associated disease DOI Creative Commons
Michael P. Fautsch, Eric D. Wieben, Keith H. Baratz

et al.

Progress in Retinal and Eye Research, Journal Year: 2020, Volume and Issue: 81, P. 100883 - 100883

Published: July 28, 2020

Fuchs endothelial corneal dystrophy (FECD) is a common cause for heritable visual loss in the elderly. Since first description of an association between FECD and polymorphisms situated within transcription factor 4 (TCF4) gene, genetic molecular studies have implicated intronic CTG trinucleotide repeat (CTG18.1) expansion as causal variant majority patients. To date, several non-mutually exclusive mechanisms been proposed that drive and/or exacerbate onset disease. These include (i) TCF4 dysregulation; (ii) toxic gain-of-function from repeat-containing RNA; (iii) repeat-associated non-AUG dependent (RAN) translation; (iv) somatic instability CTG18.1. However, relative contribution these disease pathogenesis currently unknown. In this review, we summarise research implicating pathogenesis, define phenotype-genotype correlations CTG18.1 expansion, provide update on tools are available to study Furthermore, ongoing international efforts develop novel expansion-mediated therapeutics highlighted forward-thinking perspective key unanswered questions remain field.

Language: Английский

Patterns of CAG repeat instability in the central nervous system and periphery in Huntington’s disease and in spinocerebellar ataxia type 1 DOI Creative Commons
Ricardo Mouro Pinto, Larissa Arning,

James Victor Giordano

et al.

Human Molecular Genetics, Journal Year: 2020, Volume and Issue: 29(15), P. 2551 - 2567

Published: July 4, 2020

The expanded HTT CAG repeat causing Huntington's disease (HD) exhibits somatic expansion proposed to drive the rate of onset by eliciting a pathological process that ultimately claims vulnerable cells. To gain insight into in humans, we performed comprehensive quantitative analyses ~50 central nervous system (CNS) and peripheral postmortem tissues from seven adult-onset one juvenile-onset HD individual. We also assessed ATXN1 brain regions an individual with neurologically pathologically distinct disorder, spinocerebellar ataxia type 1 (SCA1). Our findings reveal similar profiles tissue instability all individuals, which, notably, were apparent SCA1 was observed tissues, but different degrees, multiple cortical neostriatum tending have greatest CNS, liver periphery. These patterns indicate propensities for contributed locus-independent trans-factors demonstrate per se is not sufficient cause cell or disease-specific pathology. Rather, pathology may reflect toxic processes triggered lengths across types diseases. find length-dependent propensity reflected cerebrospinal fluid. data cells be useful source measure biomarker assays therapeutic efforts, prompting efforts dissect underlying mechanisms differ between

Language: Английский

Citations

99

Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases DOI
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral

et al.

European Journal of Pharmaceutics and Biopharmaceutics, Journal Year: 2020, Volume and Issue: 149, P. 192 - 217

Published: Jan. 23, 2020

Language: Английский

Citations

97

Huntington’s Disease Pathogenesis: Two Sequential Components DOI Creative Commons
Eun Pyo Hong,

Marcy E. MacDonald,

Vanessa C. Wheeler

et al.

Journal of Huntington s Disease, Journal Year: 2021, Volume and Issue: 10(1), P. 35 - 51

Published: Feb. 9, 2021

Historically, Huntington’s disease (HD; OMIM #143100) has played an important role in the enormous advances human genetics seen over past four decades. This familial neurodegenerative disorder involves variable onset followed by consistent worsening of characteristic abnormal movements along with cognitive decline and psychiatric disturbances. HD was first autosomal for which genetic defect assigned to a position on chromosomes using only linkage analysis common DNA polymorphisms. discovery set off multitude similar studies other diseases, while gene, later renamed HTT, its vicinity chromosome 4p16.3 then acted as proving ground development technologies clone sequence genes based upon their genomic location, growing momentum such fueling Human Genome Project. The identification gene not yet led effective treatment, but continued genotype-phenotype relationships large subject populations, at HTT locus subsequently genome-wide, provided insights into pathogenesis that divide course two sequential, mechanistically distinct components.

Language: Английский

Citations

87

DNA Mismatch Repair and its Role in Huntington’s Disease DOI Creative Commons

Ravi R. Iyer,

Anna Pluciennik

Journal of Huntington s Disease, Journal Year: 2021, Volume and Issue: 10(1), P. 75 - 94

Published: Feb. 9, 2021

DNA mismatch repair (MMR) is a highly conserved genome stabilizing pathway that corrects replication errors, limits chromosomal rearrangements, and mediates the cellular response to many types of damage. Counterintuitively, MMR also involved in generation mutations, as evidenced by its role causing somatic triplet repeat expansion Huntington’s disease (HD) other neurodegenerative disorders. In this review, we discuss current state mechanistic knowledge review roles key enzymes pathway. We present evidence for mutagenic function CAG consider hypotheses have been proposed. Understanding may shed light on potential avenues therapeutic intervention HD.

Language: Английский

Citations

85

TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat-associated disease DOI Creative Commons
Michael P. Fautsch, Eric D. Wieben, Keith H. Baratz

et al.

Progress in Retinal and Eye Research, Journal Year: 2020, Volume and Issue: 81, P. 100883 - 100883

Published: July 28, 2020

Fuchs endothelial corneal dystrophy (FECD) is a common cause for heritable visual loss in the elderly. Since first description of an association between FECD and polymorphisms situated within transcription factor 4 (TCF4) gene, genetic molecular studies have implicated intronic CTG trinucleotide repeat (CTG18.1) expansion as causal variant majority patients. To date, several non-mutually exclusive mechanisms been proposed that drive and/or exacerbate onset disease. These include (i) TCF4 dysregulation; (ii) toxic gain-of-function from repeat-containing RNA; (iii) repeat-associated non-AUG dependent (RAN) translation; (iv) somatic instability CTG18.1. However, relative contribution these disease pathogenesis currently unknown. In this review, we summarise research implicating pathogenesis, define phenotype-genotype correlations CTG18.1 expansion, provide update on tools are available to study Furthermore, ongoing international efforts develop novel expansion-mediated therapeutics highlighted forward-thinking perspective key unanswered questions remain field.

Language: Английский

Citations

79